SavedAdd your journal

Journals / Turkish Journal of Hematology / 2013 / Cilt: 30 - Sayı: 1

Carbamazepine and multiple myeloma: Possible interaction

Karbamazepin ve multipl miyelom: Olası ilişki

Vehbi ERÇOLAK
Çiğdem AFŞAR USUL
Semra PAYDAŞ
Berna DUMAN BOZKURT
Meral GÜNALDI
Veysel HAKSÖYLER
Pages
83–84
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ERÇOLAK, V., USUL, Ç. A., PAYDAŞ, S., BOZKURT, B. D., GÜNALDI, M., HAKSÖYLER, V. (2022). Carbamazepine and multiple myeloma: Possible interaction. Turkish Journal of Hematology, Cilt: 30 - Sayı: 1, 83–84. https://ajindex.com/articles/606917

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bell GS, Sander JW. The epidemiology of epilepsy: the size of the problem. Seizure 2001;10:306-314
  2. White SJ, McLean AEM, Howland C. Anticonvulsant drugs and cancer: a cohort study in patients with severe epilepsy. Lancet 1979;2:458-461
  3. Sander JW. The epidemiology of epilepsy revised. Curr Opin Neurol 2003;16:165-170
  4. Olsen JH, Schulgen G, Boice JD Jr, Whysner J, Travis LB, Williams GM, Johnson FB, McGee JO. Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res 1995;55:294-297
  5. Tohen M, Castillo J, Baldessarini RJ, Zarate C Jr, Kando JC. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry 1995;152:413-418
  6. Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North Am 1999;13:1181-1202
  7. Matzner Y, Polliack A. Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy. Isr J Med Sci 1978;14:1265-1267
  8. Voutsinas D, Foudoulaki L, Sofroniadou K, Galanakis N. Visceral leishmaniasis in a patient with acquired hypogammaglobulinemia. Eur J Intern Med 2001;12:127-129
  9. Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow up. Cancer Res 1989;49:5736-5747
  10. Kanoh T, Dobashi H, Inada T. Multiple myeloma associated with phenytoin (diphenylhydantoin) therapy. Rinsho Ketsueki 1996;37:239-243
  11. Moreno-Ancillo A, Cosmes Martín PM, Domínguez-Noche C, Martín-Núñez G, Fernández-Galán MA, López-López R, González-Hurtado JA, Gil-Adrados AC. Carbamazepine induced transient monoclonal gammopathy and immunodeficiency. Allergol Immunopathol (Madr) 2004;32:86-88
  12. Adelöw C, Ahlbom A, Feychting M, Johnsson F Schwartzbaum J, Tomson T. Epilepsy as a risk factor for cancer. J Neurol Neurosurg Psychiatry 2006;77:784-786.